Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/19/2008EP1899333A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1
03/19/2008EP1899332A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
03/19/2008EP1899331A1 Homomorpholine oxazolidinones as antibacterial agents
03/19/2008EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
03/19/2008EP1899329A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
03/19/2008EP1899327A1 Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole)
03/19/2008EP1899326A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
03/19/2008EP1899325A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
03/19/2008EP1899324A2 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
03/19/2008EP1899323A2 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
03/19/2008EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase
03/19/2008EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
03/19/2008EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
03/19/2008EP1899316A1 Benzopyranone compounds for treating cancer
03/19/2008EP1899315A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
03/19/2008EP1899314A2 High yield synthesis methods for producing organic salts of strontium
03/19/2008EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor
03/19/2008EP1899307A1 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands
03/19/2008EP1899305A1 Helix 12 directed non-steroidal antiandrogens
03/19/2008EP1899304A1 5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof
03/19/2008EP1899303A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/19/2008EP1899302A1 Phenoxy acetic acids as ppar delta activators
03/19/2008EP1899301A1 Novel 3-aza-spiroý5.5¨undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/19/2008EP1899298A2 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
03/19/2008EP1899297A1 Zofenopril calcium in polymorph form c
03/19/2008EP1899296A1 Histamine-3 receptor antagonists
03/19/2008EP1899295A2 Prostaglandin derivatives
03/19/2008EP1899294A1 Therapeutic agents
03/19/2008EP1899011A1 Alpha-2 adrenergic agonists for the treatment of pain
03/19/2008EP1898961A1 Method and composition to individualize levodopa/carbidopa therapy using a breath test
03/19/2008EP1898957A1 Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
03/19/2008EP1898953A1 Quadraphasic continuous graduated estrogen contraceptive
03/19/2008EP1898952A2 Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
03/19/2008EP1898937A1 Heparin coating of biological tissue
03/19/2008EP1898936A1 Method of cancer treatment using sirna silencing
03/19/2008EP1898935A2 North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses
03/19/2008EP1898934A1 Nucleosides with non-natural bases as anti-viral agents
03/19/2008EP1898933A1 Composition based on an avermectine and benzoyl peroxide in particular for treating rosacea
03/19/2008EP1898932A2 Avermectin and hydrocortisone-based composition, in particular for roracea treatment
03/19/2008EP1898930A2 Treatment of inflammatory conditions
03/19/2008EP1898929A2 A carbohydrate fraction and use thereof for a flat postprandial glucose response
03/19/2008EP1898928A2 Non-nucleoside reverse transcriptase inhibitors
03/19/2008EP1898927A2 Non-nucleoside reverse transcriptase inhibitors
03/19/2008EP1898926A2 Thyromimetics for the treatment of fatty liver diseases
03/19/2008EP1898925A2 Method for the treatment of acne
03/19/2008EP1898924A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
03/19/2008EP1898923A1 Aromatase inhibitors for emergency contraception
03/19/2008EP1898922A2 Improved drug or pharmaceutical compounds and a preparation thereof
03/19/2008EP1898921A1 Compositions and methods for treating sleep disorders
03/19/2008EP1898920A1 Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant
03/19/2008EP1898919A2 A method of treatment of hormone depletion induced vasomotor symptoms
03/19/2008EP1898918A1 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
03/19/2008EP1898917A1 Aminopyrimidines as kinase modulators
03/19/2008EP1898916A2 Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
03/19/2008EP1898915A2 Combinations of eszopiclone and an antidepressant, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
03/19/2008EP1898914A1 Quinoline derivatives as antibacterial agents
03/19/2008EP1898913A1 Multiple active drug-resin conjugate
03/19/2008EP1898912A1 Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
03/19/2008EP1898911A1 Nanoparticulate clopidogrel and aspirin combination formulations
03/19/2008EP1898910A1 Quinoline derivatives as antibacterial agents
03/19/2008EP1898909A1 Quinoline derivatives as antibacterial agents
03/19/2008EP1898908A2 Novel chemical compounds and the uses thereof as a medicament
03/19/2008EP1898907A1 Composition based on an avermectine and metronidazole in particular for treating rosacea
03/19/2008EP1898906A2 Methods of treatment utilizing certain melatonin derivatives
03/19/2008EP1898905A2 Hydroisoindoline tachykinin receptor antagonists
03/19/2008EP1898904A2 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
03/19/2008EP1898903A2 Inhibitors of akt activity
03/19/2008EP1898902A2 Compositions and methods of use of derivatized flavanols
03/19/2008EP1898901A2 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
03/19/2008EP1898900A2 Antimicrobial compositions comprising esters of hydroxycarboxylic acids
03/19/2008EP1898899A1 Inhibitors of fibroblast activation protein alpha
03/19/2008EP1898898A2 Benzoyl peroxide compositions and methods of use
03/19/2008EP1898897A2 Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
03/19/2008EP1898896A2 Topical skin treating compositions
03/19/2008EP1898895A2 Treatment of drug abuse
03/19/2008EP1898894A1 Mrp iv inhibitors for the treatment of respiratory diseases
03/19/2008EP1898893A1 Antimicrobial and antiinflammatory composition
03/19/2008EP1898890A1 Modified and immediate release memantine bead formulation
03/19/2008EP1898888A2 Formulations of conjugated estrogens and bazedoxifene
03/19/2008EP1898885A1 Methods and dosage forms for reducing side effects of carbamate compounds
03/19/2008EP1898884A2 Manufacturing process for tigecycline
03/19/2008EP1898882A2 Nanoparticulate ebastine formulations
03/19/2008EP1898879A1 Rapidly absorbing oral formulations of pde5 inhibitors
03/19/2008EP1898876A1 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
03/19/2008EP1898873A1 Gelatin-containing topical composition
03/19/2008EP1898849A2 New regimens for controlled drug delivery devices for contraception
03/19/2008EP1898832A1 Fast degrading polymers
03/19/2008EP1898721A1 Method for producing an aqueous suspension and a powdered preparation of one or more carotinoids
03/19/2008EP1898719A2 Nutritional formulations containing octenyl succinate anahydride-modified tapioca starch
03/19/2008EP1898712A2 Fortified cereal bran to promote digestive health
03/19/2008EP1898707A2 Process for preparing malathion for pharmaceutical use
03/19/2008EP1898702A2 Methods of modifying insulin signaling using biliverdin reductase
03/19/2008EP1898701A1 Delivery of active proteins to the central nervous system using phage vectors
03/19/2008EP1898692A2 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
03/19/2008EP1819663B1 Omega-phenyloctanamides
03/19/2008EP1805138B1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor
03/19/2008EP1778696B1 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
03/19/2008EP1732878A4 Method for the synthesis of quaternary ammonium compounds and compositions thereof
03/19/2008EP1730098A4 Method of exchanging anions of tetraalkylammonium salts
03/19/2008EP1720544B1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
1 ... 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 ... 7860